Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis
- PMID: 15758841
- DOI: 10.1097/01.md.0000158825.87055.0b
Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis
Abstract
We reviewed the medical records of 62 patients with systemic small and medium-sized vessel vasculitides and gastrointestinal tract involvement followed at our institution between 1981 and 2002. This group included 46 men and 16 women (male:female ratio, 2.9), with a mean age of 48 +/- 18 years. Vasculitides were distributed as follows: 38 polyarteritis nodosa (21 related to hepatitis B virus), 11 Churg-Strauss syndrome, 6 Wegener granulomatosis, 4 microscopic polyangiitis, and 3 rheumatoid arthritis-associated vasculitis. Gastrointestinal manifestations were present at or occurred within 3 months of diagnosis in 50 (81%) patients and were mainly abdominal pain in 61 (97%), nausea or vomiting in 21 (34%), diarrhea in 17 (27%), hematochezia or melena in 10 (16%), and hematemesis in 4 (6%). Gastroduodenal ulcerations were detected endoscopically in 17 (27 %) patients, esophageal in 7 (11%), and colorectal in 6 (10%), but histologic signs of vasculitis were found in only 3 colon biopsies. Twenty-one (34%) patients had a surgical abdomen; 11 (18%) developed peritonitis, 9 (15%) had bowel perforations, 10 (16%) bowel ischemia/infarction, 4 (6%) intestinal occlusion, 6 (10%) acute appendicitis, 5 (8%) cholecystitis, and 3 (5%) acute pancreatitis. (Some patients had more than 1 condition.) Sixteen (26%) patients died.The respective 10-month and 5-year survival rates were 71% (95% confidence interval [CI], 52-90) and 56% (95% CI, 35-77) for the 21 surgical patients; and 94% (95% CI, 87-101) and 82% (95% CI, 70-94) for the 41 patients without surgical abdomen (p = 0.08). Peritonitis (hazard ratio [HR] = 4.3, p < 0.01), bowel perforations (HR = 5.7, p < 0.01), gastrointestinal ischemia or infarctions (HR = 4.1, p < 0.01), and intestinal occlusion (HR = 5.5, p < 0.01) were the only gastrointestinal manifestations significantly associated with increased mortality in multivariate analysis. For this subgroup of 15 patients, 6-month and 5-year survival rates were 60% (95% CI, 35-85) and 46% (95% CI, 19-73), respectively (p = 0.003). None of the other gastrointestinal or extraintestinal vasculitis-related symptoms, or angiographic abnormalities (seen in 67% of the 39 patients who underwent angiography), was predictive of surgical complications or poor outcome. However, prognosis has dramatically improved during the past 30 years, probably owing to better management of these more severely ill patients, with prompt surgical intervention when indicated, and the combined use of steroids and immunosuppressants.
Similar articles
-
Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients.Medicine (Baltimore). 2005 Sep;84(5):323-330. doi: 10.1097/01.md.0000180793.80212.17. Medicine (Baltimore). 2005. PMID: 16148732
-
[Abdominal and digestive manifestations in systemic vasculitides].Ann Med Interne (Paris). 2003 Nov;154(7):457-67. Ann Med Interne (Paris). 2003. PMID: 14732837 Review. French.
-
Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.Int J Rheum Dis. 2014 Jun;17(5):562-72. doi: 10.1111/1756-185X.12223. Epub 2013 Nov 14. Int J Rheum Dis. 2014. PMID: 24237487 Review.
-
Gastrointestinal manifestations of systemic vasculitis.Q J Med. 1983 Spring;52(206):141-9. Q J Med. 1983. PMID: 6604292
-
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.Medicine (Baltimore). 2011 Jan;90(1):19-27. doi: 10.1097/MD.0b013e318205a4c6. Medicine (Baltimore). 2011. PMID: 21200183
Cited by
-
Clinical course and outcomes of childhood-onset granulomatosis with polyangiitis.Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):202-208. Epub 2016 Oct 6. Clin Exp Rheumatol. 2017. PMID: 27749233 Free PMC article.
-
Unusual upper gastrointestinal bleeding: Ruptured superior mesenteric artery aneurysm in rheumatoid arthritis.World J Gastroenterol. 2013 Jul 28;19(28):4630-2. doi: 10.3748/wjg.v19.i28.4630. World J Gastroenterol. 2013. PMID: 23901242 Free PMC article.
-
Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.Rheum Dis Clin North Am. 2018 Feb;44(1):89-111. doi: 10.1016/j.rdc.2017.09.005. Rheum Dis Clin North Am. 2018. PMID: 29149929 Free PMC article. Review.
-
Human hepatitis viruses-associated cutaneous and systemic vasculitis.World J Gastroenterol. 2021 Jan 7;27(1):19-36. doi: 10.3748/wjg.v27.i1.19. World J Gastroenterol. 2021. PMID: 33505148 Free PMC article. Review.
-
Initial diagnosis of Wegener's granulomatosis mimicking severe ulcerative colitis: a case report.J Med Case Rep. 2013 May 29;7:141. doi: 10.1186/1752-1947-7-141. J Med Case Rep. 2013. PMID: 23718545 Free PMC article.
References
-
- Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S. Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant. 2000;15:611-618.
-
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
-
- Babian M, Nasef S, Soloway G. Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol. 1998;93:119-120.
-
- Bailey M, Chapin W, Licht H, Reynolds JC. The effects of vasculitis on the gastrointestinal tract and liver. Gastroenterol Clin North Am. 1998;27:747-782.
-
- Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford). 2002;41:1126-1132.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous